1009-9921
2015 Issue 7
..............page:385-387
Mutational profiling in patients with myeloproliferative neoplasms: ready for every-day use in the clinic?
Xiao Zhijian;
Xiao Zhijian;
..............page:388-391
Advances in the treatment of JAK2 V617F gene mutation positive myeloproliferative neoplasms
Lin Fengru;,Wang Yan;,Zhang Jingyu;
Lin Fengru;,Wang Yan;,Zhang Jingyu;
..............page:392-393
..............page:393,前插1-前插2
The diagnosis and treatment of Philadelphia chromosome-negative myeloproliferative neoplasms:evaluation of JAK2 V617F gene mutation
Cao Xinxin;,Shen Ti;
Cao Xinxin;,Shen Ti;
..............page:394-399
Development of pathogenesis and therapeutics in myeloproliferative neoplasms
Qiu Quan;,Wang Mangju;,Zhu Ping;
Qiu Quan;,Wang Mangju;,Zhu Ping;
..............page:400-404
Research progress of JAK1/2 inhibitors in the treatment of myeloproliferative neoplasms
Mei Shuhao;,Lu Jin;
Mei Shuhao;,Lu Jin;
..............page:405-407,411
Advances in pathogenesis and treatment of myeloproliferative neoplasms
Huang Dayong;,Wang Zhao;
Huang Dayong;,Wang Zhao;
..............page:408-411
Advances and enlightenment of myeloproliferative neoplasms associated gene mutations in thrombophilia and general population
Chen Xue;,Zhang Yang;,Liu Hongxing;
Chen Xue;,Zhang Yang;,Liu Hongxing;
..............page:412-414,419
Abnormal clones and clonal evolution of bcr-abl-negative myeloproliferative neoplasms
Xu Na;,Ding Li;,Liu Xiaoli;
Xu Na;,Ding Li;,Liu Xiaoli;
..............page:415-419
Biological characteristics and clinical implications of CALR mutations in classic myeloproliferative neoplasms
Hui Wuhan;,Tian Ding;
Hui Wuhan;,Tian Ding;
..............page:420-423,427
Analysis of protein tyrosine phosphatase 1B gene mutation in myeloproliferative neoplasms
Zhou Lili;,Fu Jianfei;,Wu Hao;,Li Bing;,Liang Aibin;
Zhou Lili;,Fu Jianfei;,Wu Hao;,Li Bing;,Liang Aibin;
..............page:424-427
Mutation analysis of myeloproliferative neoplasms associated genes in patients first diagnosed as acute ischemic stroke
tian wen jun ;, ren xiao xiao ;, chen xue ;, liu xiao hui ;, zhang yang ;, zuo wen ;, chen yong jin ;, sun hui ;, wang fang ;
tian wen jun ;, ren xiao xiao ;, chen xue ;, liu xiao hui ;, zhang yang ;, zuo wen ;, chen yong jin ;, sun hui ;, wang fang ;
..............page:428-430,436
Relationship between JAK2 V617F gene mutation and vascular embolism diseases
Zhang Wei;,Liu Yan;,Wan Suigui;,Zhao Hong;,Sun Wanling;,Tian Ding;
Zhang Wei;,Liu Yan;,Wan Suigui;,Zhao Hong;,Sun Wanling;,Tian Ding;
..............page:431-432
Clinical analysis of JAK2 V617F gene mutation in 120 patients with myeloproliferative neoplasms
dong ying ;, zhu hua feng ;, hou li ping ;, feng miao juan ;, xin xiao li ;, tian zhi qiang ;, yu shu chun ;, gao guang xun ;, chen xie qun ;
dong ying ;, zhu hua feng ;, hou li ping ;, feng miao juan ;, xin xiao li ;, tian zhi qiang ;, yu shu chun ;, gao guang xun ;, chen xie qun ;
..............page:433-436
Study on the pathological features of the bone marrow and JAK2 V617F gene mutation in patients with primary myelofibrosis
su xiao li ;, feng miao juan ;, hou li ping ;, zhu hua feng ;, chang zi wei ;, tian zhi qiang ;, yu shu chun ;, yu yan ;, gao guang xun ;
su xiao li ;, feng miao juan ;, hou li ping ;, zhu hua feng ;, chang zi wei ;, tian zhi qiang ;, yu shu chun ;, yu yan ;, gao guang xun ;
..............page:437-439
zhen xing hong xi bao zeng duo zheng ji xing sui xi bai xue bing zhuan hua er li bing wen xian fu xi
ye xiu peng ;, bao shen ;, li ye qiong ;, wei yu ping ;, zhi feng ;, guo ying ;, bai jie ;, li fang ;, jin li yuan ;
ye xiu peng ;, bao shen ;, li ye qiong ;, wei yu ping ;, zhi feng ;, guo ying ;, bai jie ;, li fang ;, jin li yuan ;
..............page:440-441
man xing zhong xing li xi bao bai xue bing yi li bing wen xian fu xi
song lin ;, jing li ping ;, zhang feng kui ;
song lin ;, jing li ping ;, zhang feng kui ;
..............page:442-444
gan rao su -2b zhi liao yuan fa xing xue xiao ban zeng duo zheng 36 li
wu xiao xie ;, zhao li dong ;, miao lei ;, xue lian guo ;, wang ying ;, cai zhi mei ;, yan jing xiu ;
wu xiao xie ;, zhao li dong ;, miao lei ;, xue lian guo ;, wang ying ;, cai zhi mei ;, yan jing xiu ;
..............page:444-445
jak2 v617f ji bcr-abl shuang yang xing man xing li xi bao bai xue bing yi li bing wen xian fu xi
xin xiao li ;, zhu hua feng ;, hou li ping ;, feng miao juan ;, dong ying ;, chang zi wei ;, tian zhi qiang ;, yu shu chun ;, gao guang xun ;
xin xiao li ;, zhu hua feng ;, hou li ping ;, feng miao juan ;, dong ying ;, chang zi wei ;, tian zhi qiang ;, yu shu chun ;, gao guang xun ;
..............page:446-447
yuan fa xing xue xiao ban zeng duo zheng yi li bing wen xian fu xi
wang jing rong ;, su li ping ;, gui zuo ;, guan tao ;, liu xiao lan ;, zhang zong ;, huang yun peng ;
wang jing rong ;, su li ping ;, gui zuo ;, guan tao ;, liu xiao lan ;, zhang zong ;, huang yun peng ;
..............page:447-448